Mentions:
1: Lord Bellamy (Con - Life peer) any inquest into a death involving Covid-19 to be held with a jury.As noble Lords will recall, the Coronavirus - Speech Link
2: Baroness Hodgson of Abinger (Con - Life peer) coming home from hospital and, the next minute, was on an end-of-life pathway due to having picked up coronavirus - Speech Link
Mentions:
1: Kevin Hollinrake (Con - Thirsk and Malton) Businesses who have made use of the previous coronavirus loan schemes, or the recovery loan scheme, will - Speech Link
Mentions:
1: Gareth Bacon (Con - Orpington) I beg to move,That the draft Coroners (Suspension of Requirement for Jury at Inquest: Coronavirus) - Speech Link
2: Gareth Bacon (Con - Orpington) inquests to be carried out and expedited as quickly as possible.As part of covid-19 easements, the Coronavirus - Speech Link
Report May. 24 2024
Committee: Public Administration and Constitutional Affairs CommitteeFound: Dr Federico Botta, TEB09 ; UKSA, TEB17 . 25 ONS Data Science Campus, Case study: responding to the coronavirus
Asked by: Lord Weir of Ballyholme (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what estimate they have made of the number of excess deaths that have arisen as a consequence of restrictions and lockdowns arising from the COVID-19 pandemic.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Excess deaths are the difference between the number of registered deaths and the number expected based on previous trends. Weekly estimates of excess deaths are published by the Office for National Statistics (ONS). Its latest data shows that for the years 2020 to 2022, there were an estimated 151,506 estimated excess deaths in England.
It is likely that deaths from COVID-19 were a large driver of excess deaths in the peak pandemic periods. Deaths were above the expected level for most of the second half of 2021, and from March 2022 until the summer of 2023; however, deaths have been below the expected level for most weeks since then.
The drivers of excess deaths are not fully understood, and the excess is likely to be the net effect of many complex and potentially related factors. The attribution of excess deaths to these factors is complex and beyond the scope of the ONS methodology. The UK Health Security Agency has estimated the excess deaths due to acute factors, such as heatwaves, cold snaps, COVID-19 and influenza.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, how many people have been convicted for breaching covid-19 restrictions since January 2022.
Answered by Gareth Bacon - Parliamentary Under-Secretary (Ministry of Justice)
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, on what date NHS England informed patients receiving the Oxford-AstraZeneca Covid-19 vaccine that there were safety risks of vaccine-induced thrombosis with thrombocytopenia associated with the vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
To ensure informed consent was given by patients who received the AstraZeneca COVID-19 vaccine, all vaccination sites were instructed to follow consent guidance in line with the recommendations set out in chapter two of the UK Health Security Agency Green Book on vaccinations and immunisations.
Healthcare organisations administering any COVID-19 vaccinations are responsible for drawing up their own policies for obtaining informed consent, and health professionals overseeing or administering COVID-19 vaccines are responsible for ensuring that valid consent has been obtained. This would normally involve a discussion with the clinician prior to the administration of the vaccine, and individuals will also have had access to guides and patient information leaflets which provided details about the vaccine, how it is administered, possible side effects, and other warnings and precautions to take.
Regarding the very rare adverse events of concurrent thrombosis and thrombocytopenia associated with the AstraZeneca COVID-19 vaccine, NHS England notified healthcare organisations administering the COVID-19 vaccinations immediately following the updated advice from the independent Joint Committee on Vaccination and Immunisation published on 7 April 2021, and then again following updated advice on 7 May 2021. In these updates, sent via system letters, NHS England set out the next steps for healthcare organisations and clinicians, including on the consent process.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps NHS England took to ensure that informed consent was given by recipients of the Oxford-AstraZeneca covid-19 vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
To ensure informed consent was given by patients who received the AstraZeneca COVID-19 vaccine, all vaccination sites were instructed to follow consent guidance in line with the recommendations set out in chapter two of the UK Health Security Agency Green Book on vaccinations and immunisations.
Healthcare organisations administering any COVID-19 vaccinations are responsible for drawing up their own policies for obtaining informed consent, and health professionals overseeing or administering COVID-19 vaccines are responsible for ensuring that valid consent has been obtained. This would normally involve a discussion with the clinician prior to the administration of the vaccine, and individuals will also have had access to guides and patient information leaflets which provided details about the vaccine, how it is administered, possible side effects, and other warnings and precautions to take.
Regarding the very rare adverse events of concurrent thrombosis and thrombocytopenia associated with the AstraZeneca COVID-19 vaccine, NHS England notified healthcare organisations administering the COVID-19 vaccinations immediately following the updated advice from the independent Joint Committee on Vaccination and Immunisation published on 7 April 2021, and then again following updated advice on 7 May 2021. In these updates, sent via system letters, NHS England set out the next steps for healthcare organisations and clinicians, including on the consent process.
May. 23 2024
Source Page: Plan for Jobs Cross-cutting Evaluation Wave 1 and 2 synthesis reportFound: 978-1-78659-677-2, RR 1055 PDF, 1.73 MB, 194 pages Details Research background During the coronavirus
Mentions:
1: Rebecca Harris (Con - Castle Point) 2024.Debate on a motion to approve the draft Coroners (Suspension of Requirement for Jury at Inquest: Coronavirus - Speech Link